- BIXT Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
-
Shorts
-
8-K Filing Data
Bioxytran (BIXT) 8-K16 Nov 22Bioxytran Releases Positive Top-line Results from Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-printFinancial data
Company Profile